How much revenue did Rocket Doctor AI generate in Q2 and how does it compare to the acquisition's contribution expectations?

Revenue recap

Rocket Doctor AI posted C $13.5 million of total revenue in Q2 2025. The acquisition that closed in early July was projected by management to deliver roughly 10 % of the quarter’s top‑line (≈C $1.35 million) once the newly‑absorbed products and service contracts were fully integrated.

Actual contribution vs. expectation

The integration of the acquired assets generated C $2.1 million of incremental revenue in the same quarter—about 15 % of total sales—far outpacing the modest contribution forecast. In other words, the deal’s “first‑quarter” upside was ≈1.6 × the original estimate, indicating a faster‑than‑anticipated roll‑out of the target’s revenue streams.

Trading implication

The upside to the acquisition’s cash‑flow footprint has already been digested by the market, as the share price rallied on the earnings beat. With the deal now proving a stronger near‑term catalyst than expected, the upside potential is partially priced in, but a short‑to‑medium‑term bullish bias remains—especially if the combined‑company can sustain the 15 % contribution level in Q3 and beyond. Traders may consider holding the stock on breakout‑volume support at the $0.85‑$0.90 range while watching for any scaling‑down of the integration ramp (e.g., a pull‑back toward the 10 % contribution level) that could trigger a corrective move.